To improve human health by accelerating the world’s transition to precision medicine.
To disrupt the healthcare and wellness sector by deploying genomics-based intellectual property to clinical trials and healthcare providers.
Highly accomplished management team, consultants, board of directors and advisors that provide vision and leadership in the science, technology and financial aspects of the business.
Groundbreaking applications for initiating new clinical trials, assisting current trials and repositioning therapeutics from failed clinical trials.
Proprietary genomic analytics pioneered through 10,000 case studies by one of the world’s leading geneticists whose past research collaboration has been short-listed for the Nobel Prize in medicine.
Innovative digital health platform for infectious diseases built by our Global Services team using our AI and machine learning platform.
Novel risk-assessment tool for insurance industry derived from the digital health platform.